- Home
- AXIL vs VNRX Comparison
AXIL vs VNRX Comparison
Compare AXIL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXIL
- VNRX
- Stock Information
- Founded
- AXIL 2015
- VNRX N/A
- Country
- AXIL United States
- VNRX United States
- Employees
- AXIL N/A
- VNRX N/A
- Industry
- AXIL Package Goods/Cosmetics
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AXIL Consumer Discretionary
- VNRX Health Care
- Exchange
- AXIL Nasdaq
- VNRX Nasdaq
- Market Cap
- AXIL 52.6M
- VNRX 52.4M
- IPO Year
- AXIL N/A
- VNRX N/A
- Fundamental
- Price
- AXIL $8.50
- VNRX $0.71
- Analyst Decision
- AXIL
- VNRX Strong Buy
- Analyst Count
- AXIL 0
- VNRX 5
- Target Price
- AXIL N/A
- VNRX $3.88
- AVG Volume (30 Days)
- AXIL 17.9K
- VNRX 155.3K
- Earning Date
- AXIL 08-14-2025
- VNRX 08-13-2025
- Dividend Yield
- AXIL N/A
- VNRX N/A
- EPS Growth
- AXIL 93.65
- VNRX N/A
- EPS
- AXIL 0.29
- VNRX N/A
- Revenue
- AXIL $27,007,463.00
- VNRX $1,308,361.00
- Revenue This Year
- AXIL N/A
- VNRX $563.72
- Revenue Next Year
- AXIL N/A
- VNRX $160.43
- P/E Ratio
- AXIL $28.88
- VNRX N/A
- Revenue Growth
- AXIL N/A
- VNRX 64.16
- 52 Week Low
- AXIL $3.54
- VNRX $0.40
- 52 Week High
- AXIL $10.75
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- AXIL 78.76
- VNRX 50.77
- Support Level
- AXIL $6.50
- VNRX $0.69
- Resistance Level
- AXIL $8.85
- VNRX $0.80
- Average True Range (ATR)
- AXIL 0.76
- VNRX 0.05
- MACD
- AXIL 0.26
- VNRX -0.00
- Stochastic Oscillator
- AXIL 91.05
- VNRX 40.00
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.